The Future... Today
From breakthrough cosmetics to advanced gastrointestinal health therapies, Zyme Fast delivers biotech innovations that last for generations.
40+
Years of industry experience
25+
Break-through products in our portfolio
23+
Introducing Zyme Fast —
How we innovate
Bridging the gap between human health, cosmetics, and animal nutrition with advanced innovative biotech.
Human Health products
Our human health line includes groundbreaking products to combat severe gastrointestinal infections including:
- C. difficile – C diff is a mostly hospital acquired gastrointestinal bacterial infection costing the US health-care system $7.8 billion annually. In vitro and in vivo testing show high efficacy, with only human trials remaining before market launch. The need for this product is urgent. The product is both prophylactic and remedial and aims to reduce hospital-acquired infections and improve gastrointestinal health for countless patients.
- E coli 0157 H7 – This bacterium is also known as “hamburger disease.” The bacterium produces Shiga toxin which attacks the infected individuals’ organs. The first organ attacked is usually the kidneys resulting in a high mortality rate. Recent outbreaks include the outbreak at several McDonalds (US) locations and baby carrots in both the US and Canada. Positive in vitro test results.
- Helicobacter pylori - H pylori infect 50% of the world’s population. H pylori cause 95% of gastric ulcers and the majority of gastric cancers. The product is again both prophylactic and remedial. A published study claims this bacterium cost the Japanese healthcare system $1.4 billion annually.
Small Molecule Peptides for Cosmetics
- Epidermal Growth Factor – EGF is an effective cosmetic ingredient that reduces the signs of aging. This includes wrinkle reduction, increased collagen and elastin production.
- Fibroblast Growth Factor - FGF aids in wound healing, reduces the signs of aging including collagen and elastin production.
- Superoxide Dismutase - SOD is a powerful antioxidant that aids anti-aging, skin health, and inflammatory skin conditions.
Animal Health and Feed Additives
Through our subsidiary in Changsha, China, we provide animal feed additives that enhance growth and immunity without the use of antibiotics, offering a sustainable solution for large-scale farming. This division includes virus-targeted products, immune support, and appetite enhancers, supporting healthier livestock and higher yields.
This divisions’ products include bacterium and virus-targeted products and appetite enhancers that support healthier livestock with higher yields and lower costs.
Why partner with us
Zyme Fast Inc. is at the forefront of biotechnology since 2001, creating transformative solutions that combat gastrointestinal pathogens.
Cost Leadership
Our proprietary production techniques reduce costs by up to 99%, offering unmatched pricing for high-demand molecules.
Global Reach
With established facilities in Canada and China, Zyme Fast serves North American, Asian, and European markets.
First-Mover Advantage
Zyme Fast holds exclusive EYA-based solutions for C. diff, E. coli, and H. pylori, poised to solidify our place as industry leaders.
Proven Leadership Team
CEO Stan Schroeder and CSO Dr. Lin Fang bring a combined 75+ years of experience in biotech and strategic growth, paving the way for sustained innovation and expansion.
Our company growth
Pioneering cost-effective biotech solutions through cutting-edge recombinant technology and unmatched efficiency.
Founding Vision
Established by scientists from the University of Manitoba to revolutionize gastrointestinal health using recombinant technology.
Early Success in Animal Nutrition
Launched proprietary feed additives, introducing groundbreaking egg yolk antibody (EYA) products to control livestock gastrointestinal pathogens.
Expansion to China
Opened Zyme Fast (Changsha) Biotechnology Co. Ltd., complete with a high-capacity facility processing 1 million eggs per day and a pollution-free chicken farm.
First Human Health Applications
Began developing antibodies and vaccines targeting critical human pathogens such as C. difficile, E. coli, and H. pylori.
ISO Certification Achieved
Secured ISO 9001:2008 and ISO 22000 certifications, ensuring top-tier quality and safety standards at its Changsha facility.
Breakthrough in Advanced Vaccines
Completed in-vitro and in-vivo testing for EYA-based solutions, demonstrating effectiveness against gastrointestinal pathogens.
Largescale Farming Market Entry
Adding dozens of new targeted solutions for problem bacterium and virus’ that plague largescale farming.
Rapid Growth in R&D
Innovated low-cost production methods for small molecules, reducing costs of small molecule proteins significantly, setting a new industry benchmark.
Leadership Transition
With new CEO Stan Schroeder, the company refocused on global expansion and advancing its human health portfolio.
Innovating the Future
Positioned as a global leader in biotech, ready to launch solutions for superbugs, skin health, and animal nutrition.
Transforming Health, Beauty, and Animal Care
Innovative products harness the power of recombinant technologies
Advanced human health solutions
- Gastrointestinal health antibodies
- Skin repair molecules
- Future focus
Revolutionary animal health additives
- Passive immunity vaccines
- Advanced formulations for disease prevention
- Rapid-flow lateral assay test kits
High-impact cosmetic ingredients
- Epidermal Growth Factor (EGF)
- Fibroblast Growth Factor (FGF)
- Superoxide Dismutase (SOD)
Diagnostic and vaccine innovations
- Rapid-flow lateral assay kits
- Passive immunity vaccines
Advanced formulations for long-lasting disease prevention.
Small Molecule Peptides
Canada Facility
🇨🇦
R&D lab and headquarters in Manitoba, supporting North American market operations.
China Facility
🇨🇳
Located in Changsha, it includes a state-of-the-art egg processing plant capable of handling one million eggs per day. Certified for quality (ISO9001:2008) and food safety, Zyme Fast China produces antibody-rich products for animal health and pet markets.
Our Core Team
CEO & President
Stan Schroeder
With 40+ years of leadership in national and international sales, Stan Schroeder steers Zyme Fast’s vision, focusing on new market strategies and company growth.
Chief Science Officer
Dr. Lin Fang
Dr. Fang, a biotech pioneer, has spearheaded the development of 25+ protein-based products and oversees all R&D at Zyme Fast.
